Certainly an interesting income play. My concern: is the high dividend sustainable? $ 1.44 is 74% higher than the current upper-end FY10 net income estimate of $ 0.83, and over 50% above the FY11 estimate of $ 0.95. Retained earnings are nearly depleted, so Vince may need to pull some magic in order to maintain the nice payout.
NPS Pharmaceuticals: Good News on Horizon? [View article]
Although I agree that NPSP is an interesting company, it is misleading that you left out their massive LT debt of nearly 300M, 74M of current payables, or the fact they are spending more on interest expense than R&D.
Cramer's Mad Money - Dividends Don't Lie (4/20/10) [View article]
WWE Drop-Kicks the Competition [View article]
WWE Drop-Kicks the Competition [View article]
NPS Pharmaceuticals: Good News on Horizon? [View article]